KARACHI: Sindh Infectious Diseases Hospital & Research Centre, Karachi, is conducting a COVID-19 booster vaccine trial.
Individuals aged 18 years or above who have received both doses of Sinopharm or Sinovac vaccine and have no prior history of COVID infection would participate in this trial.
Drug Regulatory Authority of Pakistan (DRAP), National Bioethics Committee Pakistan (NBC) and Dow University of Health Sciences Institutional Review Board (DUHS IRB) have approved this COVID-19 booster vaccine trial.
The institute would provide free medical care, examination facility and incentives to the volunteers.
Editorial: Clinical trials have been a kind of research that analyses new tests and treatments and assesses their effects on human health outcomes.
